Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.878 USD | -0.23% | 0.00% | +4.52% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
Financials (USD)
Sales 2022 | 218M | Sales 2023 | 136M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2022 | 182M | Net income 2023 | 108M | EV / Sales 2022 | 5.19 x |
Net cash position 2022 | 121M | Net cash position 2023 | 135M | EV / Sales 2023 | 7.07 x |
P/E ratio 2022 |
7.11
x | P/E ratio 2023 |
10.1
x | Employees | - |
Yield 2022 |
7.37% | Yield 2023 |
8.33% | Free-Float | 88.58% |
1 day | -0.23% | ||
1 month | +0.46% | ||
3 months | -5.39% | ||
6 months | +7.07% | ||
Current year | +4.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hyman
CHM | Chairman | 67 | 17-02-26 |
Duncan Budge
BRD | Director/Board Member | 68 | - |
Director/Board Member | - | 18-12-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.878 | -0.23% | 668,307 |
24-05-09 | 0.88 | 0.00% | 304,380 |
24-05-08 | 0.88 | -0.23% | 1,489,063 |
24-05-07 | 0.882 | +0.46% | 3,502,594 |
24-05-03 | 0.878 | -0.23% | 2,145,874 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.52% | 1.07B | |
+5.34% | 12.82B | |
+12.72% | 9.62B | |
+9.66% | 5.64B | |
-0.50% | 5.56B | |
+6.41% | 5.23B | |
+17.95% | 4.63B | |
+18.80% | 4.53B | |
+2.81% | 4.07B | |
+6.22% | 3.94B |
- Stock Market
- Equities
- BPCP Stock